Literature DB >> 33829948

Estimating the basic reproductive number of varicella in South Korea incorporating social contact patterns and seroprevalence.

Taeyong Lee1, Jiyeon Suh2, Jae-Ki Choi3, Jeehyun Lee1,2, Sun Hee Park3.   

Abstract

Varicella, which is caused by the varicella zoster virus (VZV), is a common infectious disease affecting children. Varicella vaccines have been used for decades; however, vaccination policies vary across countries because of differences in VZV epidemiology. The basic reproductive number R0 a transmissibility measure parameter, also differs from country to country. In this study R0 for varicella was estimated in South Korea using the contact rate matrix derived from averaged POLYMOD contact data, the Korean population, and proportionality factor fitted to the Korean VZV seroprevalence R0 for varicella in South Korea was estimated to be 5.67 (95% CI: 5.33, 6.33). Therefore, to reach the herd immunity threshold, the critical vaccine coverage should be greater than 82.4% with a perfect vaccine, or the primary vaccine failure proportion should be less than 17.6% with 100% coverage. Because of the relatively low seroconversion rate and rapidly waning immunity after one-dose vaccination in South Korea, the herd immunity threshold is difficult to attain with only a one-dose vaccine. Two doses of vaccination may be necessary to effectively interrupt varicella transmission and maintain herd immunity in South Korea. The study results can help guide the decision-making on an effective varicella vaccination policy in South Korea.

Entities:  

Keywords:  Korea; Varicella; basic reproductive number; contact patterns; herd immunity threshold

Mesh:

Substances:

Year:  2021        PMID: 33829948      PMCID: PMC8475589          DOI: 10.1080/21645515.2021.1898917

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  23 in total

Review 1.  Mathematical models of vaccination.

Authors:  Almut Scherer; Angela McLean
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

2.  Infections with varying contact rates: application to varicella.

Authors:  H J Whitaker; C P Farrington
Journal:  Biometrics       Date:  2004-09       Impact factor: 2.571

3.  What types of contacts are important for the spread of infections?: using contact survey data to explore European mixing patterns.

Authors:  Alessia Melegaro; Mark Jit; Nigel Gay; Emilio Zagheni; W John Edmunds
Journal:  Epidemics       Date:  2011-05-13       Impact factor: 4.396

4.  Seroprevalence rate after one dose of varicella vaccine in infants.

Authors:  So Hee Kim; Hoan Jong Lee; Su Eun Park; Sung Hee Oh; Seong Yeon Lee; Eun Hwa Choi
Journal:  J Infect       Date:  2010-04-07       Impact factor: 6.072

5.  Burden of varicella in the Asia-Pacific region: a systematic literature review.

Authors:  Anne Eng Neo Goh; Eun Hwa Choi; Kulkanya Chokephaibulkit; Jaydeep Choudhury; Barbara Kuter; Ping-Ing Lee; Helen Marshall; Jin Oh Kim; Lara J Wolfson
Journal:  Expert Rev Vaccines       Date:  2019-04-14       Impact factor: 5.217

Review 6.  Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses.

Authors:  Paolo Bonanni; Anne Gershon; Michael Gershon; Andrea Kulcsár; Vassiliki Papaevangelou; Bernard Rentier; Catherine Sadzot-Delvaux; Vytautas Usonis; Timo Vesikari; Catherine Weil-Olivier; Peter de Winter; Peter Wutzler
Journal:  Pediatr Infect Dis J       Date:  2013-07       Impact factor: 2.129

7.  The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region.

Authors:  A Nardone; F de Ory; M Carton; D Cohen; P van Damme; I Davidkin; M C Rota; H de Melker; J Mossong; M Slacikova; A Tischer; N Andrews; G Berbers; G Gabutti; N Gay; L Jones; S Jokinen; G Kafatos; M V Martínez de Aragón; F Schneider; Z Smetana; B Vargova; R Vranckx; E Miller
Journal:  Vaccine       Date:  2007-08-08       Impact factor: 3.641

8.  Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

Authors:  David E Michalik; Sharon P Steinberg; Philip S Larussa; Kathryn M Edwards; Peter F Wright; Ann M Arvin; Haley A Gans; Anne A Gershon
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

9.  Epidemiology of Breakthrough Varicella after the Implementation of a Universal Varicella Vaccination Program in Taiwan, 2004-2014.

Authors:  Hao-Yuan Cheng; Luan-Yin Chang; Chun-Yi Lu; Li-Min Huang
Journal:  Sci Rep       Date:  2018-11-21       Impact factor: 4.379

Review 10.  Global Varicella Vaccine Effectiveness: A Meta-analysis.

Authors:  Mona Marin; Melanie Marti; Anita Kambhampati; Stanley M Jeram; Jane F Seward
Journal:  Pediatrics       Date:  2016-02-16       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.